Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of the Modified PUQE ( Pregnancy -Unique Quantification of Emesis ) Score on Admitted Cases of Hyperemesis Gravidarum (HG) to Guide Response to Treatment

NCT04785911 is registered in ClinicalTrials.gov with Tasnem Abo-elouon as lead sponsor.

NCT NCT04785911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04785911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of the Modified PUQE ( Pregnancy -Unique Quantification of Emesis ) Score on Admitted Cases of Hyperemesis Gravidarum (HG) to Guide Response to Treatment
Lead sponsor
Tasnem Abo-elouon
Phase
Observational
Overall status
Completed
Start date
September 5, 2021
Completion date
November 1, 2022
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperemesis gravidarum